References
1. Sattar N, Lee MMY, Kristensen SL, et al. Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials. lancet Diabetes Endocrinol. 2021;9(10):653-662. doi:10.1016/S2213-8587(21)00203-5
2. Sarma S, Palcu P. Weight loss between glucagon-like peptide-1 receptor agonists and bariatric surgery in adults with obesity: A systematic review and meta-analysis. Obesity (Silver Spring). 2022;30(11):2111-2121. doi:10.1002/OBY.23563
3. Drucker DJ. The benefits of GLP-1 drugs beyond obesity. Science. 2024;385(6706):258-260. doi:10.1126/SCIENCE.ADN4128
4. Wharton S, Davies M, Dicker D, et al. Managing the gastrointestinal side effects of GLP-1 receptor agonists in obesity: recommendations for clinical practice. Postgrad Med. 2022;134(1):14-19. doi:10.1080/00325481.2021.2002616
5. Klein SR, Hobai IA. Semaglutide, delayed gastric emptying, and intraoperative pulmonary aspiration: a case report. Can J Anaesth. 2023;70(8):1394-1396. doi:10.1007/S12630-023-02440-3
6. Gulak MA, Murphy P. Regurgitation under anesthesia in a fasted patient prescribed semaglutide for weight loss: a case report. Can J Anaesth. 2023;70(8):1397-1400. doi:10.1007/S12630-023-02521-3
7. Yeo YH, Gaddam S, Ng WH, et al. Increased Risk of Aspiration Pneumonia Associated With Endoscopic Procedures Among Patients With Glucagon-like Peptide 1 Receptor Agonist Use. Gastroenterology. 2024;167(2):402-404.e3. doi:10.1053/J.GASTRO.2024.03.015
8. Silveira SQ, da Silva LM, de Campos Vieira Abib A, et al. Relationship between perioperative semaglutide use and residual gastric content: A retrospective analysis of patients undergoing elective upper endoscopy. J Clin Anesth. 2023;87. doi:10.1016/J.JCLINANE.2023.111091
9. Sherwin M, Hamburger J, Katz D, DeMaria S. Influence of semaglutide use on the presence of residual gastric solids on gastric ultrasound: a prospective observational study in volunteers without obesity recently started on semaglutide. Can J Anaesth. 2023;70(8):1300-1306. doi:10.1007/S12630-023-02549-5
10. Ushakumari DS, Sladen RN. ASA Consensus-based Guidance on Preoperative Management of Patients on Glucagon-like Peptide-1 Receptor Agonists. Anesthesiology. 2024;140(2):346-348. doi:10.1097/ALN.0000000000004776
11. Elangovan A, Aggarwal P, Kaelber DC, Shah R. RATES OF REPEAT EGD IN NON-DIABETIC ADULTS WITH GLUCAGON-LIKE-PEPTIDE- 1 RECEPTOR AGONIST PRESCRIPTION: A RETROSPECTIVE MATCHED COHORT STUDY. Gastrointest Endosc. October 2024. doi:10.1016/J.GIE.2024.10.004
12. Alkabbani W, Suissa K, Gu KD, et al. Glucagon-like peptide-1 receptor agonists before upper gastrointestinal endoscopy and risk of pulmonary aspiration or discontinuation of procedure: cohort study. BMJ. 2024;387:e080340. doi:10.1136/BMJ-2024-080340
13. Singh S, Rahman SH, Khan N, et al. Effects of glucagon-like peptide-1 receptor agonists on endoscopy outcomes: A systematic review & meta-analysis. Gastrointest Endosc. October 2024. doi:10.1016/J.GIE.2024.10.011
14. Al Sakka Amini R, Ismail A-LS, Al-Aqrabawi M, et al. Risk of Aspiration Pneumonitis After Elective Esophagogastroduodenoscopy in Patients on Glucagon-Like Peptide-1 Receptor Agonists. Cureus. 2024;16(8). doi:10.7759/CUREUS.66311
15. Hashash JG, Thompson CC, Wang AY. AGA Rapid Clinical Practice Update on the Management of Patients Taking GLP-1 Receptor Agonists Prior to Endoscopy: Communication. Clin Gastroenterol Hepatol. 2024;22(4):705-707. doi:10.1016/J.CGH.2023.11.002
16. Chang MG, Bittner EA. Comparison of societal guidance on perioperative management of glucagon-like peptide-1 receptor agonists: implications for clinical practice and future investigations. Can J Anaesth. 2024;71(9). doi:10.1007/S12630-024-02810-5
17. Jalleh RJ, Rayner CK, Hausken T, Jones KL, Camilleri M, Horowitz M. Gastrointestinal effects of GLP-1 receptor agonists: mechanisms, management, and future directions. lancet Gastroenterol Hepatol. 2024;9(10):957-964. doi:10.1016/S2468-1253(24)00188-2
18. Kindel TL, Wang AY, Wadhwa A, et al. Multisociety Clinical Practice Guidance for the Safe Use of Glucagon-like Peptide-1 Receptor Agonists in the Perioperative Period. Clin Gastroenterol Hepatol. October 2024. doi:10.1016/J.CGH.2024.10.003
19. Crespo J, Terán Á. Endoscopy and sedation: an inseparable binomial for the gastroenterologist. Rev Esp enfermedades Dig. 2018;110(4):250-252. doi:10.17235/REED.2018.5585/2018